Clinical Trial Update: Bioavailability, Bioequivalence and Tolerability of IHL-42X Compared to the Reference Drugs [Phase 1]

View source ↗

Summary

Phase 1 study evaluating bioavailability, bioequivalence and tolerability of IHL-42X compared with reference drugs in obstructive sleep apnea has been completed…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Obstructive Sleep Apnea

Drugs mentioned

• IHL-42X

Snippet

Sponsor: Incannex Healthcare Ltd | Conditions: Obstructive Sleep Apnea | Phase 1 | Status: COMPLETED